Viewing Study NCT05946460

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-27 @ 11:53 PM
Study NCT ID: NCT05946460
Status: RECRUITING
Last Update Posted: 2024-02-06
First Post: 2023-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity.
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Aumolertinib View
None Neoadjuvant Treatment View
None AI-diagnosed View
None EGFR-mutant View
None Ground-glass Opacity View